IP priorities over the commercial lifecycle

Corporate IP strategy evolves over time, often radically so. IP strategy should track behind and serve the broader corporate strategy. There are always exceptions where the IP strategy is the commercial, or the IP strategy contains significant architectural features that interleave with commercial strategy. But for most companies IP strategy serves. There are a few main emphases that change the priorities of an IP strategy. These are:

• Commercial launch asks what must be secured before the product is public, and whether the company is free to sell it.
• Venture funding asks whether the position survives someone else's audit.
• Exit asks whether the rights can be handed over cleanly.
• Enforcement asks whether the rights hold when someone is paid to break them.

A company's IP gets examined several times over its commercial life. At launch, the key is deciding what to protect before the product goes public. At a funding round, satisfying an investor's counsel is critical. At exit, a buyer's advisers. In a dispute, a competitor's litigators.

The four phases run in nominal chronological order, as the corporate matures. Businesses skip stages, repeat them, and sometimes meet a copycat before they meet an investor. The shift in priorities holds regardless, and so does a more useful point: every later examination reads decisions made in an earlier phase, often by people who weren't thinking about it at the time.

Product launch: the disclosure clock sets the ceiling

Product launch is the one phase where the company controls the timetable. It is also where the most consequential decisions get made with the least scrutiny. Once a product is public, the window for novelty starts to close. Australia and the United States offer limited grace periods for an inventor's own disclosure. Europe and China largely do not. A launch without priority filings can quietly remove the markets a later investor expects to see covered.

The priorities are practical:

• An inventory of new features, sorted into what to patent, what to keep as a trade secret, and what to publish defensively
• A freedom-to-operate view before committing to the product, not after
• Priority filings lodged before public release, drafted around what a competitor can be seen doing
• Development discipline, because open-source licence terms the dev team accepts or grants can give away patent rights before anyone has decided to file

None of this needs a large budget. It needs the decisions to be made deliberately, and recorded.

Venture investment: the portfolio is audited, not admired

Investors don't value IP in diligence. They search it for defects: ownership gaps, disclosure before filing, claims that protect the prototype rather than the product, and encumbrances that narrow what the company can do with what it says it owns. Whatever the company asserts about its IP comes back as a warranty in the subscription agreement.

The priority shifts from securing rights to evidencing them. That means executed assignments, a live register, licences in and out, and an open-source inventory. It also means a short note mapping the rights that matter to the features that earn revenue. A documented decision not to file reads as judgment. Silence reads as absence.

Exit: value is measured by what can be transferred

A buyer is acquiring the ability to use and defend the IP without the seller. Trade buyers, private equity, public markets and successors each ask a different question. All of those questions depend on the same condition: rights held by the right entity, unencumbered, documented, and assignable without anyone else's permission.

Exit diligence looks backwards, and it is unforgiving. It reads the whole history, across restructures and long-departed contributors. Price moves on things like:

• Change-of-control clauses
• Undischarged security interests
• Rights filed in a founder's name
• Know-how that lives only in someone's head

Warranties survive completion, so these findings keep costing after the deal closes. Legibility is worth more than scale. A register an adviser can understand in an afternoon draws fewer questions, and fewer questions mean fewer chances to reprice.

Litigation: strength is tested by an adversary

Enforcement puts the right on trial. An infringement claim invites a revocation counterclaim, and the other side will read the specification more carefully than the examiner did. A single right makes for a fair fight. Layered rights across patents, designs, trade marks and trade secrets make competing expensive, and most of their value comes from disputes that never begin.

Litigation sits last in the sequence, but it can arrive at any point. Positions are built years before they are used:

• Claims that track the market rather than the prototype
• Claims drafted around what can be observed
• Something kept pending, so the claims can still be shaped

Once a dispute starts, the specification is fixed. Sequence matters too. Under Australian law, a demand sent before the position has been assessed can expose the sender to an unjustified threats claim.

The sequence runs forward, the decisions run backward

Read together, the four phases share an uncomfortable structure. Each examination tests work completed in an earlier phase, and each makes that work more expensive to repair.

• A disclosure made at launch becomes a venture finding
• A missing contractor assignment at the raise becomes an exit indemnity
• A claim drafted around the prototype becomes a failed enforcement

The cost of a defect rises with each phase. That is because the fix increasingly depends on someone else's signature or cooperation, and that person increasingly understands what it is worth.

What carries across every phase

A small set of disciplines serves all four readers at once:

• Clean ownership, consolidated in the operating entity and kept there through every restructure
• Claims that follow the product as it changes
• A register that reconciles to the official record
• Recorded reasons for what was filed, kept secret, or deliberately left alone
• A regular rehearsal of the next examination, while findings are still cheap to fix

Priorities shift across the commercial lifecycle because the audience shifts: from founders, to investors, to buyers, to adversaries. The foundations do not shift. IP that is owned, scoped to the product and documented as it is built will answer every one of those readers. IP that isn't will be found out by whichever reader arrives first.